Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 283515011000036115 | irinotecan | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 283516011000036110 | irinotecan (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| irinotecan | Is a | medicinal product | true | Inferred relationship | Some | ||
| irinotecan | has intended active ingredient | irinotecan | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| irinotecan hydrochloride trihydrate 500 mg/25 mL injection, vial | Is a | True | irinotecan | Inferred relationship | Some | |
| irinotecan hydrochloride trihydrate 40 mg/2 mL injection, vial | Is a | True | irinotecan | Inferred relationship | Some | |
| irinotecan hydrochloride trihydrate 100 mg/5 mL injection, vial | Is a | True | irinotecan | Inferred relationship | Some | |
| irinotecan hydrochloride trihydrate 150 mg/7.5 mL injection, vial | Is a | True | irinotecan | Inferred relationship | Some | |
| irinotecan hydrochloride trihydrate 300 mg/15 mL injection, vial | Is a | True | irinotecan | Inferred relationship | Some | |
| irinotecan 43 mg/10 mL injection, vial | Is a | True | irinotecan | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR